William G. Harris - Jul 30, 2021 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jul 30, 2021
Transactions value $
-$4,741
Form type
4
Date filed
8/3/2021, 04:05 PM
Previous filing
Jun 4, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +16.5K +20.72% $0.00 96K Jul 30, 2021 Direct F1
transaction SLNO Common Stock Tax liability -$4.74K -5.21K -5.43% $0.91 90.8K Jul 30, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of SLNO common stock. The RSUs are fully vested on July 30, 2021.
F2 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.